ARCHIVES

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

This article is from The Cancer Letter archive.

Vol. 19 No. 13 | March 26, 1993

Download PDF Visit The Full Archive

Related Articles

M.D. Anderson, Madrid In Joint Program

September 2, 1988

NCI-Approved Clinical Trials

June 24, 2005

Taking on question of cost and outcomes, CMS turns to expert in cancer care quality.

June 3, 2005

In Brief: James Carr Replaces Murphy As Interim Director of Organ Systems Coordinating Center In N.Y.

August 16, 1985

NCI’s SBIR Awards Move Up In Quality; Congress considers Making It Permanent; FASEB Object

September 19, 1986

Funding Opportunities: NKCA Offers Young Researcher Award

March 6, 1998